Cidara Therapeutics, Inc.
CDTXNASDAQHealthcare
$221.38
+$0.00(+0.00%)
Market Cap$5.6B
P/E Ratio—
52W High$221.42
52W Low$15.22
Cidara Therapeutics, Inc. (CDTX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CDTX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $189.82M | $35.78M | $32.73M | $62.27M | $35.91M |
| Net Receivables | $1.69M | $16.25M | $5.83M | $5.36M | $11.18M |
| Inventory | $0.00M | $6.10M | $0.00M | ($2.59M) | $0.00M |
| Total Current Assets | $210.74M | $60.85M | $45.09M | $71.70M | $57.19M |
| PP&E Net | $3.96M | $5.13M | $1.32M | $2.54M | $1.21M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $214.80M | $67.03M | $47.49M | $75.33M | $60.42M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $2.59M | $7.02M |
| Accounts Payable | $3.61M | $3.77M | $1.45M | $1.30M | $4.57M |
| Total Current Liabilities | $49.55M | $67.42M | $41.40M | $34.02M | $38.56M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $51.49M | $75.24M | $61.92M | $53.75M | $49.71M |
| Stockholders Equity | |||||
| Retained Earnings | ($611.26M) | ($441.43M) | ($418.50M) | ($377.17M) | ($334.70M) |
| Total Stockholders Equity | $163.31M | ($8.21M) | ($14.44M) | $21.57M | $10.71M |
| Total Liab & Equity(computed) | $214.80M | $67.03M | $47.49M | $75.33M | $60.42M |
| Debt Summary | |||||
| Total Debt | $3.58M | $4.88M | $1.21M | $5.06M | $7.96M |
| Net Debt | ($186.25M) | ($30.90M) | ($31.52M) | ($57.21M) | ($27.95M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Cidara Therapeutics, Inc. data
About Cidara Therapeutics, Inc. (CDTX) Balance Sheet
Cidara Therapeutics, Inc. (CDTX) balance sheet shows total assets of $0.21B with cash of $0.19B. Total liabilities are $0.05B, total debt $0.00B, and stockholders equity $0.16B.
Frequently asked questions
CDTX · 4 questionsCidara Therapeutics, Inc. has total debt of $0.00B with net debt of ($0.19B).
CDTX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10